Prospective Study Links Recent Common Colds to Short-Term Lower COVID-19 Risk
Interferon-based immune priming in the airways appears to blunt SARS-CoV-2 acquisition.
Overview
- Published on August 11 in The Journal of Infectious Diseases, the analysis drew on the nationwide HEROS cohort of more than 4,100 participants across 1,394 U.S. households.
- People with a recent rhinovirus detection were less likely to test positive for SARS-CoV-2 in the following weeks, with the effect most pronounced in children.
- Thousands of self-collected nasal swabs and airway gene-expression profiles linked recent viral exposure to elevated interferon responses.
- Authors describe the finding as heterologous viral interference and report the first prospective evidence of this phenomenon involving SARS-CoV-2.
- Researchers caution against trying to catch a cold, saying any protection appears temporary and that the biology may guide future prevention strategies for vulnerable groups.